Bawei Chenxiang Wan Ameliorates Cardiac Hypertrophy by Activating AMPK/PPAR- α Signaling Pathway Improving Energy Metabolism

In conclusion, BCW prevents ISO-induced cardiomyocyte hypertrophy by activating AMPK/PPAR-α to alleviate the disturbance in energy metabolism. Therefore, BCW can be used as an alternative drug for the treatment of cardiac hypertrophy.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research